Problems of interpreting exercise-induced asthma

https://doi.org/10.1016/0091-6749(73)90058-4Get rights and content

Abstract

Factors affecting exercise-induced asthma are reviewed based on studies in large numbers of children and young adults. Evidence is presented to show that running is a more potent and reproducible stimulus than cycling and that walking and swimming have a small and variable effect. The greatest amount of exercise-induced asthma is found after 6 to 8 minutes of steady-state running at a work rate equivalent to about two thirds of the working capacity of the subject. Exercise may be repeated every 2 hours throughout the day without any diminution of its effect in causing postexercise bronchoconstriction. The use of exercise in assessing drugs used to treat asthma is discussed, and the importance of the type of exercise test and the use of placebo preparations is emphasized. Serial exercise tests may be used to study the duration of protection from exercise-induced asthma afforded by drugs such as cromolyn sodium.

References (34)

  • Sir John A. Floyer

    Treatise of the asthma

    (1717)
  • S.D. Anderson et al.

    Changes in lung volumes and airways resistance after exercise in asthmatic subjects

    Am. Rev. Resp. Dis

    (1972)
  • M. Silverman et al.

    Metabolic changes preceding exercise induced bronchoconstriction

    Br. Med. J

    (1972)
  • N.M. Connolly et al.

    Assessment of the child with asthma

    J. Asthma Res

    (1970)
  • M.I. Blackhall et al.

    Effect of Intal on postexercise bronchoconstriction in asthma

  • B.G. Simmonsson et al.

    Exercise induced airways constriction

    Thorax

    (1972)
  • S.D. Anderson et al.

    Comparison of bronchoconstriction induced by cycling and running

    Thorax

    (1971)
  • Cited by (108)

    • Time-effect of montelukast on protection against exercise-induced bronchoconstriction

      2011, Respiratory Medicine
      Citation Excerpt :

      FEV1 values were plotted against time for each treatment. Percentage of protection was calculated as [(Ps − Pt)/Ps] · 100 where Ps is the percentage fall in FEV1 at the screening visit, and Pt is the fall after each treatment.24 Clinical protection was considered achieved if the percentage fall (ΔFEV1) after receiving MNT was one-half or less of the percentage fall after receiving the placebo.

    • Asthma and the Athlete

      2010, Pediatric Allergy: Principles and Practice Expert Consult: Second Edition
    • Activity-induced asthma

      2003, Pediatric Clinics of North America
    View all citing articles on Scopus
    View full text